ロード中...
RNAi Modulation of Placental sFLT1 for the Treatment of Preeclampsia.
Preeclampsia (PE) is a placentally-induced hypertensive disorder of pregnancy that is associated with significant morbidity and mortality to mothers and fetuses. Clinical manifestations of preterm PE result from excess circulating soluble vascular endothelial growth factor receptor FLT1 (sFLT1 or sV...
保存先:
| 出版年: | Nat Biotechnol |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6526074/ https://ncbi.nlm.nih.gov/pubmed/30451990 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nbt.4297 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|